Science Explorer Back to mapMap
Discussion
Institution · Araim Pharmaceuticals (United States)

Most cited papers from Araim Pharmaceuticals (United States)

Araim Pharmaceuticals (United States)

What are the most cited papers from Araim Pharmaceuticals (United States)?

The most cited paper from Araim Pharmaceuticals (United States) is "Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid" (Christopher M. Reilly, Nilamadhab Mishra, Julie M. Miller et al., 2004), with 146 citations. Next come "ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes" (144) and "The Receptor That Tames the Innate Immune Response" (137).

Showing 50 of 55 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid Christopher M. Reilly, Nilamadhab Mishra, Julie M. Miller et al. · The Journal of Immunology Open access Sep 2004 146
2 ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes Michael L. Brines, Ann N. Dunne, Monique van Velzen et al. · Molecular Medicine Open access 2014 144
3 The Receptor That Tames the Innate Immune Response Michael L. Brines, Anthony Cerami · Molecular Medicine Open access 15 Dec 2011 137
4 Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation Shazli Azmi, Maria Jeziorska, Maryam Ferdousi et al. · Diabetologia Open access 7 Jun 2019 122
5 Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy Carmel McVicar, Ross W. Hamilton, Liza M. Colhoun et al. · Diabetes Open access 13 Sep 2011 114
6 Corneal confocal microscopy: ready for prime time Ioannis Nikolaos Petropoulos, Georgios Ponirakis, Adnan Khan et al. · Clinical and Experimental Optometry 4 Mar 2019 113
7 Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study Lara Rosaline Heij, Marieke Niesters, Maarten Swartjes et al. · Molecular Medicine Open access Nov 2012 111
8 Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain Daniel A. Culver, Albert Dahan, Daiva R. Bajorunas et al. · Investigative Ophthalmology & Visual Science Open access 5 May 2017 104
9 ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber Density Albert Dahan, Ann N. Dunne, Maarten Swartjes et al. · Molecular Medicine Open access 2013 95
10 Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin Massimo Collino, Christoph Thiemermann, Anthony Cerami et al. · Pharmacology & Therapeutics Open access 26 Feb 2015 91
11 Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy Michael L. Brines, Daniel A. Culver, Maryam Ferdousi et al. · Scientific Reports Open access 12 Mar 2018 89
12 Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor Sina Maren Coldewey, Areeg I. Khan, Amar Kapoor et al. · Kidney International Open access 17 Apr 2013 76
13 Cornea nerve fiber quantification and construction of phenotypes in patients with fibromyalgia Linda C.J. Oudejans, Xuan He, Marieke Niesters et al. · Scientific Reports Open access 23 Mar 2016 65
14 Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns Stefan Bohr, Suraj J. Patel, K. Robert Shen et al. · Proceedings of the National Academy of Sciences Open access 11 Feb 2013 63
15 The mast cell plays a central role in the immune system of teleost fish Alessandra Sfacteria, Michael L. Brines, Ulrich Blank · Molecular Immunology 10 Mar 2014 61
16 A Small Nonerythropoietic Helix B Surface Peptide Based upon Erythropoietin Structure Is Cardioprotective against Ischemic Myocardial Damage Ismayil Ahmet, Hyun‐Jin Tae, Magdalena Juhaszova et al. · Molecular Medicine Open access 16 Dec 2010 55
17 ARA290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-term Relief of Neuropathic Pain Maarten Swartjes, Aurora M. Morariu, Marieke Niesters et al. · Anesthesiology 4 Oct 2011 49
18 Functional Expression of Heteromeric Calcitonin Gene-related Peptide and Adrenomedullin Receptors in Yeast Juan José Miret, Larissa Rakhilina, L. B. Silverman et al. · Journal of Biological Chemistry Open access Mar 2002 46
19 ARA 290 for treatment of small fiber neuropathy in sarcoidosis Monique van Velzen, Lara Rosaline Heij, Marieke Niesters et al. · Expert Opinion on Investigational Drugs 21 Feb 2014 41
20 ARA 290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-Term Relief of Neuropathic Pain Coupled with Suppression of the Spinal Microglia Response Maarten Swartjes, Monique van Velzen, Marieke Niesters et al. · Molecular Pain Open access 2014 37
21 A Nonerythropoietic Peptide that Mimics the 3D Structure of Erythropoietin Reduces Organ Injury/Dysfunction and Inflammation in Experimental Hemorrhagic Shock Nimesh S. A. Patel, Kiran K. Nandra, Michael L. Brines et al. · Molecular Medicine Open access 13 May 2011 35
22 Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells Stefan Bohr, Suraj J. Patel, Radovan Vasko et al. · Journal of Molecular Medicine Open access 5 Nov 2014 32
23 Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2Akita) diabetic mouse sympathetic ganglia Robert E. Schmidt, Dongyan Feng, Qiuling Wang et al. · Experimental Neurology Open access 19 Aug 2011 31
24 Quantification of small fiber pathology in patients with sarcoidosis and chronic pain using cornea confocal microscopy and skin biopsies Linda C.J. Oudejans, Marieke Niesters, Michael L. Brines et al. · Journal of Pain Research Open access Aug 2017 28
25 ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors’ Angiogenic Potential and Homing Ability Guillaume Hache, Philippe Garrigue, Youssef Bennis et al. · Shock 12 May 2016 28
26 Discovery of a Master Regulator of Injury and Healing: Tipping the Outcome from Damage toward Repair Michael L. Brines · Molecular Medicine Open access 2014 27
27 I. M. Gelfand ‐ G. E. Schilow, Verallgemeinerte Funktionen (Distributionen). Band I und II. 364 bzw. XII + 216 S. m. 5 Abb. Berlin 1960/1962. VEB Deutscher Verlag der Wissenschaften. Preis geb. DM 37,‐/ DM 27,– Detlef Laugwitz · ZAMM ‐ Journal of Applied Mathematics and Mechanics / Zeitschrift für Angewandte Mathematik und Mechanik 1963 26
28 Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin Hiroto Ueba, Masashi Shiomi, Michael L. Brines et al. · Molecular Medicine Open access 2013 25
29 Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy Ismayil Ahmet, Hyun‐Jin Tae, Michael L. Brines et al. · Journal of Pharmacology and Experimental Therapeutics Open access 13 Apr 2013 23
30 TNF and EPO: major players in the innate immune response: their discovery Anthony Cerami · Annals of the Rheumatic Diseases 28 Mar 2012 23
31 The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic Olivia E. O'Leary, Paul E. Canning, Emma Reid et al. · Experimental Eye Research Open access 12 Mar 2019 21
32 Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis Manfred Nairz, David Haschka, Stefanie Dichtl et al. · Scientific Reports Open access 6 Oct 2017 21
33 The erythropoietin analog ARA 290 for treatment of sarcoidosis-induced chronic neuropathic pain Marieke Niesters, Maarten Swartjes, Lara Rosaline Heij et al. · Expert Opinion on Orphan Drugs 17 Dec 2012 21
34 Ketamine Does Not Produce Relief of Neuropathic Pain in Mice Lacking the β-Common Receptor (CD131) Maarten Swartjes, Marieke Niesters, Lara Rosaline Heij et al. · PLoS ONE Open access Aug 2013 21
35 Corneal nerve quantification predicts the severity of symptoms in sarcoidosis patients with painful neuropathy Michael L. Brines, Maarten Swartjes, Martijn Rudolf Tannemaat et al. · TECHNOLOGY Sep 2013 19
36 Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes Alessandra Bitto, Natasha Irrera, Gabriele Pizzino et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Open access 7 Dec 2017 17
37 Bemerkungen zu Bolzanos Größenlehre Detlef Laugwitz · Archive for History of Exact Sciences Aug 1965 17
38 Targeting the innate repair receptor to treat neuropathy Albert Dahan, Michael L. Brines, Marieke Niesters et al. · PAIN Reports Open access Jul 2016 13
39 ARA290 Improves Insulin Release and Glucose Tolerance in Type 2 Diabetic Goto-Kakizaki Rats Carole Muller, Kamal Yassin, Luo-Sheng Li et al. · Molecular Medicine Open access 2015 13
40 Erythropoietin and Engineered Innate Repair Activators Michael L. Brines, Anthony Cerami · Methods in molecular biology Book chapter 2013 12
41 A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema Noemi Lois, Evie Gardner, Margaret McFarland et al. · Journal of Clinical Medicine Open access 14 Jul 2020 11
42 Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation Ming Han Yao, Anna Domogatskaya, Nils Ågren et al. · Cell Transplantation Open access 2021 9
43 The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice Zamzam Awida, Almog Bachar, Hussam Saed et al. · International Journal of Molecular Sciences Open access 21 Dec 2021 7
44 Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand Ming Han Yao, Masaaki Watanabe, Sune Sun et al. · Transplantation Open access 24 Apr 2020 6
45 Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes Mohammed Hamed Alqarni, Mohd Imran, Ahmed I. Foudah et al. · ACS Omega Open access 16 Jun 2025 5
46 The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia Sandra Palus, Yulia Elkina, Tanja Braun et al. · Journal of Cachexia Sarcopenia and Muscle Open access 18 May 2022 5
47 A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan Nolan M. Winicki, Alay P. Nanavati, Christopher H. Morrell et al. · Frontiers in Cardiovascular Medicine Open access 18 Jan 2023 3
48 An Engineered Innate Repair Receptor Agonist, ARA 290, Protects Rat Islets from Cytokine-induced Apoptosis Masaaki Watanabe, Yu Saito, Jesper Wallmo et al. · Journal of Diabetes & Metabolism Open access 2016 2
49 A Surprising Journey in Translational Medicine Anthony Cerami · Molecular Medicine Open access 2014 1
50 A. S. Petrow , Einstein‐Räume (Mathematische Lehrbücher und Monographien, II. Abteilung Mathematische Monographien, Band XIV). X + 394 S. Berlin 1964. Akademie‐Verlag. Preis geb. DM 58,‐ . Detlef Laugwitz · ZAMM ‐ Journal of Applied Mathematics and Mechanics / Zeitschrift für Angewandte Mathematik und Mechanik 1964 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.